Supermarket shoppers squeeze fruit to see if it’s ripe. The same sort of test could one day be applied to cells in a lab dish as a way of diagnosing disease. Ted Hubbard, a mechanical engineer at Dalhousie University in Halifax, Nova Scotia, has developed a pair of silicon claws small enough to squeeze individual cells just a few micrometers in diameter. Using spring-loaded joints controlled by an electrical current, the microgripper can measure the force needed to break the cells, an indicator of cellular health that could be used to test, say, blood cells for infection or cells from a biopsy to see if they are cancerous. Hubbard has shown that his device can grip dead, dry cells, and he is now developing a version able to grab live cells in liquid. He is part of a group of researchers that plans to develop, within seven years, a prototype micromachined diagnostic device incorporating the microgripper, for the lab or doctor’s office.
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
The baby formula shortage has birthed a shady online marketplace
Desperate parents just want to feed their babies. They’re having to contend with misinformation, price gouging, and scams along the way.
I tried to buy an Olive Garden NFT. All I got was heartburn.
Our newest issue spells out what you need to know about the dizzying world of digital money.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.